Artificial Intelligence
Empowering Pharmaceutical Companies in Chronic Disease Research and Identifying Unmet Needs says Disease Landscape Insights
Chronic diseases are long term ailments that progress over time. They are non-communicable in nature and can lead to severe health complications if left undetected and untreated. Chronic disease prevalence has been increasing dramatically across the globe. Unhealthy lifestyle choices, rise in the geriatric populace, environmental degradation, genetic issues, and inadequate access to quality healthcare services are some of the major factors leading to the onset of long term illness in individuals.
There is a wide range of chronic diseases affecting millions of people worldwide. Such ailments might start developing at an early age with intended affects in later years. Effective management of such ailments involve early diagnosis, accurate medical intervention, lifestyle changes, and constant monitoring, among others. Healthcare professionals including researchers and physicians along with pharma leaders are constantly involve in R&D activities with an aim to find effective diagnostic and treatment solutions for the same. World Health Organization’s chronic disease statistics 2023 denotes that long terms ailments account for 41% million deaths each year. This rate is projected to soar in the coming years.
Disease Landscape Insights has been offering healthcare consulting services to these players with an aim to enhance their understanding on chronic disorders. It boasts a comprehensive portfolio of chronic disease research documents, encompassing a wide spectrum of ailments such as anemia, diabetes, stroke, obesity, arthritis, heart diseases, and more. Within DLI’s extensive repository, these documents serve as a valuable resource, providing deep dive insights into the complexities of chronic ailments. Through DLI’s advanced platform, chronic disease market players and stakeholders gain access to a wealth of knowledge that empowers them to make well-informed decisions.
Chronic Diseases- Characteristics, Symptoms and Implications
A significant portion of the world population is living with chronic disease. The characteristics and traits of these ailments are distinct. But most of these diseases are long lasting, highly complexed, non-transmissible, and progressive. Apart from that, some of the common symptoms triggered by all chronic ailments are fatigue, sudden weight fluctuation, frequent infections, and digestive issues, among others.
The proper identification of these symptoms is crucial for healthcare professionals to diagnose the potential ailment. It is worth noting that most incurable disease including chronic ones can be regulated with proper medical intervention. DLI has been assisting players in their chronic disease assessment so that they can expedite their therapy or drug development process.
Elucidating the treatment scenario
Chronic disease treatment vertical is vast, encompassing drugs, therapies, surgical interventions, and lifestyle changes, among others. Medication adherence in chronic disease is crucial because of its progressive nature. The prescribed medicines are required to be consumed by patients to manage the symptoms and slow down the disease progress. The chronic disease management market has been gaining massive traction over the years. This is due to the increased health cognizance of the masses along with the elevating demand for highly effective treatment solutions.
Here is an overview of the chronic disease management outlook-
Lifestyle Modifications: Encouraging patients to adopt a healthy diet, exercise regularly, manage stress, and avoid smoking and excessive alcohol consumption is a common approach for many chronic diseases.
Medications: Depending on the specific chronic disease, medications may include antibiotics for chronic infections, antihypertensive drugs for high blood pressure, insulin or oral medications for diabetes, or anti-inflammatory drugs for conditions like arthritis.
Physical Therapy: Physical therapy can help manage chronic pain and improve mobility and function in conditions like osteoarthritis or chronic back pain.
Dietary Management: Dietary changes are often recommended to control chronic diseases, such as reducing sodium intake for hypertension, following a low-sugar diet for diabetes, or a low-fat diet for heart disease.
Regular Monitoring: Routine monitoring of vital signs, blood glucose levels, or other relevant markers is crucial for managing many chronic diseases.
Supportive Care: Supportive care, including palliative care and symptom management, may be necessary for advanced chronic conditions, such as cancer.
Medication Adherence: Ensuring that patients adhere to their prescribed medication regimens is vital for managing chronic diseases effectively.
Education: Providing patients with information about their condition, its management, and potential complications is essential for empowering them to take control of their health.
Surgery: In some cases, surgical interventions, such as joint replacement for osteoarthritis or coronary artery bypass surgery for advanced heart disease, may be necessary.
Mental Health Support: Managing the psychological aspects of living with a chronic disease often involves counseling or therapy to address depression, anxiety, or stress.
It is worth mentioning that the treatment plans may completely vary based on the disease type, overall health status of the patients, along with other physiological and psychological aspects.
DLI’s Extended Role in Clinical Trial Assessment
Chronic disease epidemiology study extensively conducted by DLI suggests highlight the importance of early detection and screening which in turn paves the way for real time medical intervention. It is worth noting that medical researchers and chronic disease pharmacies/pharma leaders are working efficiently to develop favourable chronic disease products that can enhance the quality of life of the patients.
But in order to get these potential products including drugs and therapies approved for commercial use, they are required to undergo a strenuous chronic disease clinical trials process. DLI has been a constant support for these players during this phase. Clinical trials are a complicated process wherein the participants are required to take care of multiple things simultaneously. Any sort of negligence may hinder the entire process. DLI through its expertise in this domain has been involved in safety monitoring, data analysis, efficacy assessment, data review, participant protection, and chronic disease regulatory compliance. By offering these services, it has helped the players ensure the real time and successful completion of the clinical trial rounds.
Post successful trials, the next step for players is to launch their products. DLI equips them with in depth product launch services and drug launch strategies, enabling them to gain market access while strengthening their market position.
Post Launch Scenario
After the drug or therapy gets approval for commercial use and is launched in the market, the players starting formulating strategies that can help their products to make huge profits. For that, they ensure if their products are showing promising results. They do so by gathering and analysing customer insights. Many players seek consulting services in their post launch phase. DLI has been successfully empowering these players with product portfolio analysis, commercial strategy analysis, pricing and reimbursement-based data, along with product portfolio extension tactics.
Final Words
The increased pervasiveness of chronic diseases is a cause of concern across numerous nations. This has pushed medical researchers and other healthcare professionals to formulate effective chronic disease management solutions. Given the complexed nature of long-term illness, navigating through this journey can be rigorous and time consuming for the players. By collaborating with Disease Landscape Insights, they are being able to expedite their R&D activities. DLI has always been focused on chronic disease medicine reimbursement, in-depth chronic disease analysis, Clinical Trial Feasibility Analysis, and the provision of valuable drug insights signifies a holistic and forward-looking strategy. These strategies aim towards alleviating economical burden for patients while ensuring the efficiency of clinical trials. DLI has joined hands with the chronic disease vertical leaders to redefine landscape of chronic disease management, offering a more comprehensive and patient-centric approach to tackling these challenging medical conditions.
Artificial Intelligence
Fractal Announces Merger of Eugenie.ai to Bolster AI-Powered Climate Solutions
MUMBAI, India, June 26, 2024 /PRNewswire/ — Fractal (www.fractal.ai), a global provider of artificial intelligence and advanced analytics solutions to Fortune 500® companies, today announced the merger of Eugenie AI (Eugenie.ai), an AI company dedicated to providing AI-driven products for climate change and industrial sustainability.
Founded in 2021, Eugenie has established itself as one of the pioneering forces in AI-driven climate solutions. Their clientele includes some of the world’s largest industrial corporations across energy, metals & mining, and other hard-to-abate sectors. Eugenie’s achievements include being featured at the prestigious 2024 Google I/O, being an alum of the Google for Startups: Climate Change accelerator and winning multiple global accolades such as the NASSCOM Emerge 50, Tech30 recognition by YourStory, and the Vedanta Spark Corporate Innovation Challenge. Eugenie has been featured as a key provider by Gartner in its 2023 Market Guide for Energy Management and Optimization Systems & Market Guide for Commercial and Industrial Energy Management and Optimization Systems.
Srikanth Velamakanni, Co-founder, Group Chief Executive & Vice Chairman, Fractal, said, “We are excited to welcome Eugenie back into the Fractal family. Eugenie’s cutting-edge AI technologies and their commitment to combating climate change align perfectly with our vision to leverage AI for social good. Together, we aim to accelerate the development and deployment of innovative solutions that address some of the most pressing environmental challenges of our time. Eugenie’s expertise in serving major industrial clients complements our goal of creating significant value for client in Fortune 100 organizations.”
Dr. Soudip Roy Chowdhury, Founder and CEO, Eugenie AI, said, “Joining forces with Fractal marks a significant milestone for Eugenie. Our shared values and complementary expertise will enable us to scale our impact and continue our mission to drive sustainable industrial transformations. We look forward to working together to create a future where technology and nature coexist harmoniously. By integrating our AI-driven solutions with Fractal’s extensive capabilities, we can offer even greater value to our clients, helping them achieve their sustainability goals.”
The merger of Eugenie reinforces Fractal’s commitment to harnessing the power of artificial intelligence to address global challenges and underscores its dedication to sustainability and innovation. By integrating Eugenie’s expertise in climate-focused AI solutions, Fractal aims to expand its portfolio and deliver even greater value to its clients and communities worldwide.
Eugenie’s focus on providing AI solutions to some of the hardest-to-abate sectors aligns perfectly with Fractal’s vision of driving significant value for large enterprises. This strategic merger will enhance Fractal’s ability to offer comprehensive AI solutions that not only optimize business operations but also contribute to a more sustainable and resilient industrial ecosystem.
For more information, please visit www.fractal.ai and www.eugenie.ai.
About Fractal
Fractal is one of the most prominent providers of Artificial Intelligence to Fortune 500® companies. Fractal’s vision is to power every human decision in the enterprise, and bring AI, engineering, and design to help the world’s most admired companies.
Fractal’s businesses include Crux Intelligence (AI driven business intelligence), Eugenie.ai (AI for sustainability), Asper.ai (AI for revenue growth management), Senseforth.ai (conversational AI for customer service) & Flyfish (generative AI for Sales). Fractal incubated Qure.ai, a leading player in healthcare AI for detecting Tuberculosis and Lung cancer.
Fractal currently has 4500+ employees across 17 global locations, including the United States, UK, Ukraine, India, Singapore, Middle East and Australia. Fractal has been recognized as ‘Great Workplace’ and ‘India’s Best Workplaces for Women’ in the top 100 (large) category by The Great Place to Work® Institute; featured as a leader in Data Engineering services 2024 & Data Science Services 2024 by Information Services Group, Leader in AI and Analytics Services Specialists Peak Matrix Assessment 2021 by Everest Group, Leader in Customer Analytics Service Providers Wave™ 2023 by Forrester Research, Inc.
About Eugenie AI:
Eugenie is a forward-thinking AI company, headquartered in NY, USA dedicated to creating solutions that address climate change and promote industrial sustainability. Leveraging advanced AI technologies, Eugenie empowers organizations to achieve their sustainability goals and contribute to a healthier planet.
View original content:https://www.prnewswire.com/in/news-releases/fractal-announces-merger-of-eugenieai-to-bolster-ai-powered-climate-solutions-302183085.html
Artificial Intelligence
ADOLFO DOMÍNGUEZ PRESENTS HIS NEW FASHION AND FRAGRANCE COLLECTION AT A WORLD FASHION SHOW
The brand intertwines fashion and perfume to create an immersive experience in the olfactory and creative universe
The fashion show, which will take place in Chile, will be broadcast online in 29 countries. It can be followed live on the brand’s website and social media profiles
MADRID, June 26, 2024 /PRNewswire/ — Adolfo Domínguez keeps moving forward in its commitment to bring fashion closer to society. The brand will showcase Ikigai, its autumn-winter 2024 collection, together with a selection of new perfumes in a global fashion show.
The event, which will mix fashion and fragrances, will be streamed live on 27 June at 6 p.m. (Portuguese time) on the brand’s website, accessible from 29 countries around the world, as well as through Mega, the main television channel in Chile, and Movistar+, in Spain. The event will also be broadcast on the company’s profiles on social media.
Adolfo Dominguez will showcase its fashion and perfume collections from the La Moneda cultural centre in Santiago de Chile, where it will create an immersive experience with artistic performances and music developed exclusively for the occasion. Attendees will have the opportunity to experience first-hand the essence and innovation that define Adolfo Dominguez, consolidating its presence and relevance in the Latin American market.
“Clothes matter. It is our second skin. Perfume is the trace we leave as we walk by. With each new collection, we explore our creativity and out contribution to society as a brand- why should we limit it to a privileged few in a room?” states Patricia Alonso, Corporate Director of Marketing and Communication at Adolfo Domínguez.
Ikigai, a Japanese concept that invites each person to go in search of their vital purpose, is the driving force behind Adolfo Domínguez’s autumn-winter 2024 collection: a selection of garments designed to liberate oneself. The result is a collection designed to be lived, with garments that are born to make people understand that beauty and happiness reside in the little things.
The fashion show will be streamed on www.adolfodominguez.com and on the brand’s profiles on social media (Youtube, Instagram and Facebook). In Latin America, the fashion show can also be seen on Mega, one of the main Chilean television channels.
Photo – https://mma.prnewswire.com/media/2444915/Adolfo_Dominguez.jpgLogo – https://mma.prnewswire.com/media/2445072/Adolfo_Dominguez_logo.jpg
View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/adolfo-dominguez-presents-his-new-fashion-and-fragrance-collection-at-a-world-fashion-show-302179102.html
TORONTO, NECKARSULM, Germany and NORTHAMPTON, UK, June 26, 2024 /PRNewswire/ — Darwin CX and dsb deepen their alliance as Darwin CX becomes a shareholder of dsb. The Canadian company’s investment in dsb expands Darwin CX into the UK and European market and dsb becomes part of the pioneering Darwin CX family. The strategic partnership marks a significant milestone for Darwin CX and dsb, both leading providers of SaaS solutions and services for publishers.
The most remarkable aspect of this union is the parallel trajectories of these formidable companies prior to the partnership. Darwin CX and dsb’s fly ecosystem both launched in 2018 with the common goal of modernizing the publishing industry, which had become heavily reliant on outdated practices and legacy systems. Each company was on an independent mission to create an ecosystem of tools and solutions that would allow publishers to thrive in a fast-paced, data-driven, digital-first marketplace.
Best practices from North America meet European recipes for success
“While Darwin CX developed a platform for the needs of a North American publishing audience, the dsb fly ecosystem offers its European customers a variety of tools to increase acquisition, maximize customer lifetime value and reduce costs and effort,” explains Liam Lynch, CEO of Darwin CX.
Broader range of resources and features
Darwin CX and dsb are process experts in the publishing environment. “We know the industry’s workflows inside out and have the same vision. Now, as subscription professionals, we are joining forces and offering our customers scalable solutions that enable them to tap into new revenue streams in a dynamic market,” emphasizes Olaf Bendt, CEO of the dsb Group. “Our customers benefit from an even broader range of resources and features.”
Next generation sales and marketing solutions
Publishers are battling dwindling attention spans and declining engagement. dsb and Darwin CX offer the publishing industry new, powerful tools for even more accurate content offers, prices and subscription conditions. All of this is based on data-driven, AI-supported personalization, which offers publishers new insights into their customers’ engagement and launches targeted measures to increase loyalty.
Prioritizing business continuity
“To meet the growing needs of our customers, dsb will expand their fly back-end infrastructure while integrating some of Darwin CX’s key marketing and data management tools. Of course, business continuity will be maintained for both our European and North American clients. We will offer our clients the best of both worlds without disrupting their day-to-day business,” emphasizes Alex Münch, COO at dsb Group.
Solutions for digital and printed content
Darwin CX and dsb are united by a focus on maximizing recurring revenue, seamless integration of online and offline solutions, and a fundamental belief in customer centricity. “The DNA of both companies is the publishing industry. That’s why, together with dsb, we are focusing on customized solutions for printed and digital Content”, stresses Michael Smith, Darwin CX Co-Founder and Chief Technology Officer.
About Darwin CX
Darwin CX is a transformative SaaS and services platform at the leading edge of the subscription and membership economies. Founded in Toronto, Canada, Darwin CX assists brands accelerate acquisition and retention—and increase loyalty—through innovative and customized check-out pages, targeted audience offerings, real-time A/B testing and best-in-class analytics, paywall and customer data platform (CDP). The Darwin CX platform enables clients to have complete freedom and control over customer data in order to tailor the best possible customer experiences. Over 140 well-known publishers and more than 300 brands in the USA, Canada and Australia rely on Darwin CX for their data and subscription management needs. Led by CEO, Liam Lynch, CTO, Michael Smith, COO, Cat Kiernan and President, Cary Zel, Darwin CX is backed by a group of growth equity investors with a common theme of disrupting industries and driving digital innovation including First Ascent Ventures, New Era Capital Partners and Felicitas Global Partners.
About dsb
With dsb fly, the dsb group develops and operates Europe’s leading subscription ecosystem for the publishing industry. Key players in the media industry have been relying on dsb’s holistic and customer-centric monetization solutions for over 50 years. Whether lifestyle products, seminars, events, digital or print titles – the dsb fly ecosystem offers media companies a customized 360-degree customer view of print and digital consumption. This all-round view is the basis for highly individualized worlds of experience and high customer loyalty. dsb fly manages customer relationships along the entire customer life cycle and maximizes subscription retention and sales with accurate subscription offers and highly individualized worlds of experience.
TAGGED WITH: Darwin CX, Liam Lynch, Michael Smith, Cary Zel, dsb, dsb.net, Olaf Bendt, Alex Münch
To find out if Darwin CX and dsb are right for your international business, contact [email protected]
Photo – https://mma.prnewswire.com/media/2447856/Darwin_CX_LLC_Darwin_CX_Broadens_Global_Reach_via_Strategic_Part.jpg
View original content:https://www.prnewswire.co.uk/news-releases/darwin-cx-broadens-global-reach-via-strategic-partnership-with-dsb-302182339.html
-
Artificial Intelligence5 days agoTech Developers Pioneering AI Tools to Revolutionize Future Productivity and Logistics
-
Artificial Intelligence5 days ago2024 World Intelligence Expo kicks off in Tianjin
-
Uncategorized5 days agoDyspareunia Treatment Market to Hit $1,035.4 million by 2031, at a CAGR of 4.6%, says Coherent Market Insights
-
Artificial Intelligence5 days ago
2024 World Intelligence Expo Begins with a Grand Opening in Tianjin
-
Artificial Intelligence5 days agoEenovance Showcases Comprehensive Product Solutions at Intersolar Europe 2024
-
Artificial Intelligence5 days agoKidoodle MiniBox A1: Sowing Seeds of Imagination for Kids
-
Artificial Intelligence5 days ago
Key Tech Stocks Optimizing AI Usability and Infrastructure for a $20-Trillion Future
-
Artificial Intelligence5 days ago
Tianjin Advances with AI
